Literature DB >> 15755768

Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.

Jaime M Grubert1, Margaret Lautz, D Brooks Lacy, Mary C Moore, Ben Farmer, Angelina Penaloza, Alan D Cherrington, Owen P McGuinness.   

Abstract

The pancreas releases insulin in a pulsatile manner; however, studies assessing the liver's response to insulin have used constant infusion rates. Our aims were to determine whether the secretion pattern of insulin [continuous (CON) vs. pulsatile] in the presence of hyperglycemia 1) influences net hepatic glucose uptake (NHGU) and 2) entrains NHGU. Chronically catheterized conscious dogs fasted for 42 h received infusions including peripheral somatostatin, portal insulin (0.25 mU x kg(-1) x min(-1)), peripheral glucagon (0.9 ng x kg(-1) x min(-1)), and peripheral glucose at a rate double the glucose load to the liver. After the basal period, insulin was infused for 210 min at either four times the basal rate (1 mU x kg(-1) x min(-1)) or an identical amount in pulses of 1 and 4 min duration, followed by intervals of 11 and 8 min (CON, 1/11, and 4/8, respectively) in which insulin was not infused. A variable peripheral glucose infusion containing [3H]glucose clamped glucose levels at twice the basal level ( approximately 200 mg/dl) throughout each study. Hepatic metabolism was assessed by combining tracer and arteriovenous difference techniques. Arterial plasma insulin (microU/ml) either increased from basal levels of 6 +/- 1 to a constant level of 22 +/- 4 in CON or oscillated from 5 +/- 1 to 416 +/- 79 and from 6 +/- 1 to 123 +/- 43 in 1/11 and 4/8, respectively. NHGU (-0.8 +/- 0.3, 0.4 +/- 0.2, and -0.9 +/- 0.4 mg x kg(-1) x min(-1)) and net hepatic fractional extraction of glucose (0.04 +/- 0.01, 0.04 +/- 0.01, and 0.05 +/- 0.01 mg x kg(-1) x min(-1)) were similar during the experimental period. Spectral analysis was performed to assess whether a correlation existed between the insulin secretion pattern and NHGU. NHGU was not augmented by pulsatile insulin delivery, and there is no evidence of entrainment in hepatic glucose metabolism. Thus the loss of insulin pulsatility per se likely has little or no impact on the effectiveness of insulin in regulating liver glucose uptake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755768     DOI: 10.1152/ajpendo.00567.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 2.  Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.

Authors:  Leslie S Satin; Peter C Butler; Joon Ha; Arthur S Sherman
Journal:  Mol Aspects Med       Date:  2015-01-28

3.  Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.

Authors:  Aleksey V Matveyenko; Johannes D Veldhuis; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

4.  Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure.

Authors:  M González; U Böer; C Dickel; T Quentin; I Cierny; E Oetjen; W Knepel
Journal:  Diabetologia       Date:  2008-09-02       Impact factor: 10.122

5.  Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein.

Authors:  Aleksey V Matveyenko; Johannes D Veldhuis; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

6.  Effect of the glucagon-like peptide-1 receptor agonist lixisenatide on postprandial hepatic glucose metabolism in the conscious dog.

Authors:  Mary Courtney Moore; Ulrich Werner; Marta S Smith; Tiffany D Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-22       Impact factor: 4.310

7.  Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling.

Authors:  Aleksey V Matveyenko; David Liuwantara; Tatyana Gurlo; David Kirakossian; Chiara Dalla Man; Claudio Cobelli; Morris F White; Kyle D Copps; Elena Volpi; Satoshi Fujita; Peter C Butler
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

8.  Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse.

Authors:  W Steven Head; Meredith L Orseth; Craig S Nunemaker; Leslie S Satin; David W Piston; Richard K P Benninger
Journal:  Diabetes       Date:  2012-04-17       Impact factor: 9.461

9.  Closing in on the Mechanisms of Pulsatile Insulin Secretion.

Authors:  Richard Bertram; Leslie S Satin; Arthur S Sherman
Journal:  Diabetes       Date:  2018-03       Impact factor: 9.461

10.  The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns.

Authors:  Rei Noguchi; Hiroyuki Kubota; Katsuyuki Yugi; Yu Toyoshima; Yasunori Komori; Tomoyoshi Soga; Shinya Kuroda
Journal:  Mol Syst Biol       Date:  2013-05-14       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.